Winton Group LTD Sangamo Therapeutics, Inc Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $183,686 - $276,411	-25,197 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$9.01 - $12.01 $201,202 - $268,195	-22,331 Reduced 46.98%	25,197 $227,000
Q2 2021 Aug 10, 2021	BUY	$10.17 - $12.64 $41,300 - $51,331	4,061 Added 9.34%	47,528 $569,000
Q1 2021 Jul 21, 2021	BUY	$10.88 - $17.05 $126,795 - $198,700	11,654 Added 36.63%	43,467 $545,000
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $37,658 - $74,174	4,080 Added 14.71%	31,813 $496,000

Q3 2020 Oct 30, 2020	SELL	$9.38 - $12.48 $581,860 - $774,159	-62,032 Reduced 69.1%	27,733 $262,000
Q2 2020 Aug 05, 2020	BUY	$6.21 - $11.83 $370,097 - $705,032	59,597 Added 197.55%	89,765 $804,000
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $390,738 - $684,759	-77,374 Reduced 71.95%	30,168 $192,000
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $863,562 - $1.26 Million	107,542 New	107,542 $900,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.